Investor Alerts: PFSweb (NASDAQ:PFSW), TCP Capital (NASDAQ:TCPC), Warren Resources (NASDAQ:WRES), WuXi Pharmatech Cayman Inc. (NYSE:WX)



PFSweb (NASDAQ:PFSW) is higher after the company on Thursday reported better-than-expected financial results for Q4. Shares are up 3.18% at $9.09 in late-morning Thursday trade, near its 52-week high of $9.60. The eCommerce firm reported Q4 non-GAAP earnings of $0.06 per share, compared with the prior-year period’s $0.07 per share. The Capital IQ consensus estimate was for $0.02 per share.

PFSweb (NASDAQ:PFSW)’s GAAP loss for the quarter was $0.03 per share, compared with GAAP earnings of $0.05 per share. Revenue was $66.7 million, down from $77 million in the same quarter last year. The decrease in total revenues was primarily due to the expected decline in product revenue to $21.3 million compared to $28.3 million in the same period in 2012 as a result of restructuring activities by the company’s largest client in this segment.

Analysts were expecting revenues of $50.98 million. PFSweb (NASDAQ:PFSW) said it is currently targeting fiscal 2014 service fee equivalent revenue of $127 million – $133 million, increasing 7% – 12% from 2013. It is also targeting adjusted EBITDA in fiscal 2014 of $12 million – $14 million, representing an increase of 12% – 31% from 2013.

TCP Capital (NASDAQ:TCPC) is higher after the company reported Q4 net investment income declined year-over-year on a per share basis, though said net assets increased. Shares are up 1.55% at $17.65, with a 52-week range of $14.87 – $18.15.

The externally managed, non-diversified closed-end management investment company reported Q4 net investment income was $16.3 million, or $0.51 per share, before related incentive compensation and preferred dividends.

TCP Capital (NASDAQ:TCPC) net investment income same period last year was approximately $14.0 million, or $0.65 per share, before preferred dividends and excise taxes. Net increase in net assets resulting from operations for the current quarter was $14.4 million, or $0.46 per share, compared with $6.9 million, or $0.32 per share, in the comparable quarter a year ago.

Warren Resources (NASDAQ:WRES) was up nearly 2% in early trade as its Q4 earnings and sales topped analysts’ expectations. The oil and gas exploration and production company said its Q4 non-GAAP adjusted income rose to $0.11 per share from $0.07 the year earlier, beating the $0.09 average estimate from analysts polled by Capital IQ.

Warren Resources (NASDAQ:WRES)’s revenue rose to $32.61 million from $31.90 million a year ago, coming in just ahead of the $32 million consensus estimate. Total net income applicable to shareholders slipped however to $3.7 million from $4.0 million due to $3.4 million in unrealized, non-cash losses on commodity derivatives resulting from mark to market accounting and $0.7 million of non-recurring G&A related to severance expenses.

Warren Resources (NASDAQ:WRES) shares were down 2.67% in morning trading.

WuXi Pharmatech Cayman Inc. (NYSE:WX) fell 7.8% after providing disappointing earnings guidance. The contract drug researcher estimates Q1 expects revenue of $143 million to $145 million and earnings per ADS of $0.36 to $0.38, compared with the analyst forecast on Capital IQ of $154 million in revenue and earnings per ADS of $0.40.

For the full year 2014, the company expects revenue of $660 million to $670 million and earnings per ADS of $1.95 to $2.00, compared with the Street view of $667 million in revenue and earnings of $1.89 per ADS. WuXi (NYSE:WX) reported Q4 2013 revenue of $157.2 million, up 25.1% from the prior year and in line with the analyst consensus.

Earnings per ADS was $0.53, ahead of expectations of $0.46 per share. WuXi (NYSE:WX) fell 7.8% to $36.30 per ADS on Thursday. It reached a 52-week high of $40.72 on February 25.

 

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone